Compelling evidence suggests that inflammation, cell survival, and cancer are linked, with a central role played by NF-κB. Recent studies implicate some TLRs in tumor development based on their ability to facilitate tumor growth; however, to our knowledge, involvement of neither TLR7 nor TLR78 has yet been demonstrated. Here we have demonstrated expression of TLR7 and TLR8, the natural receptors for single-stranded RNA, by tumor cells in human lung cancer in situ and in human lung tumor cell lines. Stimulation with TLR7 or TLR8 agonists led to activated NF-κB, upregulated expression of the antiapoptotic protein Bcl-2, increased tumor cell survival, and chemoresistance. Transcriptional analysis performed on human primary lung tumor cells and TLR7- or TLR8-stimulated human lung tumor cell lines revealed a gene expression signature suggestive of chronic stimulation of tumor cells by TLR ligands in situ. Together, these data emphasize that TLR signaling can directly favor tumor development and further suggest that researchers developing anticancer immunotherapy using TLR7 or TLR8 agonists as adjuvants should take into account the expression of these TLRs in lung tumor cells.
Julien Cherfils-Vicini, Sophia Platonova, Mélanie Gillard, Ludivine Laurans, Pierre Validire, Rafaele Caliandro, Pierre Magdeleinat, Fathia Mami-Chouaib, Marie-Caroline Dieu-Nosjean, Wolf-Herman Fridman, Diane Damotte, Catherine Sautès-Fridman, Isabelle Cremer
Title and authors | Publication | Year |
---|---|---|
Toll-Like Receptor 4 and 8 are Overexpressed in Lung Biopsies of Human Non-small Cell Lung Carcinoma
Ceccarelli S, Pasqua Marzolesi V, Vannucci J, Bellezza G, Floridi C, Nocentini G, Cari L, Traina G, Petri D, Puma F, Conte C |
Lung | 2025 |
Retroelement co-option disrupts the cancer transcriptional programme
Loong J, Thompson R, Hall C, Doglio L, Pape J, Plowman T, Kassiotis G |
Genome Medicine | 2025 |
Involvement of nucleic acid-sensing toll-like receptors in human diseases and their controlling mechanisms
Lin YS, Chang YC, Pu TY, Chuang TH, Hsu LC |
Journal of Biomedical Science | 2025 |
Seasonal influenza vaccines differentially activate and modulate toll-like receptor expression within the tumor microenvironment
Gupta KH, Giurini EF, Zloza A |
Frontiers in Oncology | 2024 |
Toll-like receptors 1–9 in small bowel neuroendocrine tumors–Clinical significance and prognosis
Hiltunen N, Kemi N, Väyrynen JP, Böhm J, Kauppila JH, Huhta H, Helminen O |
PloS one | 2024 |
The Novel Fusion Protein Melittin‐MIL‐2 Exhibits Strong Antitumor Immune Effect in Lung Adenocarcinoma Cell A549
Gao W, Li W, Wang Z, Li Y, Liu M |
The Clinical Respiratory Journal | 2024 |
Rice Husk Silica Liquid Enhances Autophagy and Reduces Overactive Immune Responses via TLR-7 Signaling in Lupus-Prone Models
Kao C, Wang SW, Chen PC, Huang CY, Wei YF, Ho CH, Hong YH |
International Journal of Molecular Sciences | 2024 |
Impact of TLR9 and TLR7 gene polymorphisms on prognosis and survival of patients with oral squamous cell carcinoma
Obrenović M, Šupić G, Miyabe S, Mladenović I, Kozomara R, Jović S, Ćurčin AP, Štefik D, Stosić S, Ðurđević BV |
Biomolecules and Biomedicine | 2024 |
TLR7 Promotes Acute Inflammatory-Driven Lung Dysfunction in Influenza-Infected Mice but Prevents Late Airway Hyperresponsiveness
Miles MA, Liong S, Liong F, Trollope GS, Wang H, Brooks RD, Bozinovski S, O\u2019Leary JJ, Brooks DA, Selemidis S |
International Journal of Molecular Sciences | 2024 |
A new immune signature for survival prediction and immune checkpoint molecules in non-small cell lung cancer
Han S, Jiang D, Zhang F, Li K, Jiao K, Hu J, Song H, Ma QY, Wang J |
Frontiers in Oncology | 2023 |
Toll-Like Receptors and the Response to Radiotherapy in Solid Tumors: Challenges and Opportunities.
Haroun R, Naasri S, Oweida AJ |
Human vaccines | 2023 |
TLRs: Innate Immune Sentries against SARS-CoV-2 Infection
Mantovani S, Oliviero B, Varchetta S, Renieri A, Mondelli MU |
International journal of molecular sciences | 2023 |
β-arrestin 2 negatively regulates lung cancer progression by inhibiting the TRAF6 signaling axis for NF-κB activation and autophagy induced by TLR3 and TLR4.
Kim JY, Shin JH, Kim MJ, Kang Y, Lee JS, Son J, Jeong SK, Kim D, Kim DH, Chun E, Lee KY |
Cell Death and Disease | 2023 |
Identification of TLRs as potential prognostic biomarkers for lung adenocarcinoma
Ying J, Hong H, Yu C, Jiang M, Ding D |
Medicine | 2023 |
Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives
Mukherjee S, Patra R, Behzadi P, Masotti A, Paolini A, Sarshar M |
Frontiers in immunology | 2023 |
Study on Potential Differentially Expressed Genes in Idiopathic Pulmonary Fibrosis by Bioinformatics and Next-Generation Sequencing Data Analysis
Giriyappagoudar M, Vastrad B, Horakeri R, Vastrad C |
Biomedicines | 2023 |
TLR/WNT: A Novel Relationship in Immunomodulation of Lung Cancer
Martín-Medina A, Cerón-Pisa N, Martinez-Font E, Shafiek H, Obrador-Hevia A, Sauleda J, Iglesias A |
International journal of molecular sciences | 2022 |
The TLR7/8 agonist R848 optimizes host and tumor immunity to improve therapeutic efficacy in murine lung cancer
Zhou J, Xu Y, Wang G, Mei T, Yang H, Liu Y |
International journal of oncology | 2022 |
Microbial-Derived Toll-like Receptor Agonism in Cancer Treatment and Progression
Giurini EF, Madonna MB, Zloza A, Gupta KH |
Cancers | 2022 |
Innate and Adaptive Responses of Intratumoral Immunotherapy with Endosomal Toll-Like Receptor Agonists
Andón FT, Leon S, Ummarino A, Redin E, Allavena P, Serrano D, Anfray C, Calvo A |
Biomedicines | 2022 |
Understanding the role of Toll-like receptors in lung cancer immunity and immunotherapy
Hoden B, DeRubeis D, Martinez-Moczygemba M, Ramos KS, Zhang D |
Frontiers in immunology | 2022 |
At the crux of maternal immune activation: Viruses, microglia, microbes, and IL‐17A
Otero AM, Antonson AM |
Immunological Reviews | 2022 |
The Role of Nucleases Cleaving TLR3, TLR7/8 and TLR9 Ligands, Dicer RNase and miRNA/piRNA Proteins in Functional Adaptation to the Immune Escape and Xenophagy of Prostate Cancer Tissue
Kocic G, Hadzi-Djokic J, Colic M, Veljkovic A, Tomovic K, Roumeliotis S, Smelcerovic A, Liakopoulos V |
International journal of molecular sciences | 2022 |
Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments
S Cuzzubbo, S Mangsbo, D Nagarajan, K Habra, AG Pockley, SE McArdle |
Frontiers in immunology | 2021 |
A novel miR1983-TLR7-IFNβ circuit licenses NK cells to kill glioma cells, and is under the control of galectin-1
D Shah, A Comba, SM Faisal, P Kadiyala, GJ Baker, MS Alghamri, R Doherty, D Zamler, G Nuñez, MG Castro, PR Lowenstein |
OncoImmunology | 2021 |
A Combined TLR7/TLR9/GATA3 Score Can Predict Prognosis in Biliary Tract Cancer
V Branchi, L Esser, C Boden, A Jafari, J Henn, P Lingohr, MA Gonzalez-Carmona, M Schmitz, TJ Weismüller, CP Strassburg, S Manekeller, G Kristiansen, JC Kalff, H Matthaei, MI Toma |
Diagnostics | 2021 |
Higher TLR7 Gene Expression Predicts Poor Clinical Outcome in Advanced NSCLC Patients Treated with Immunotherapy
S Baglivo, F Bianconi, G Metro, A Gili, FR Tofanetti, G Bellezza, B Ricciuti, M Mandarano, V Teti, A Siggillino, MS Reda, R Chiari, L Pistola, A Sidoni, V Minotti, F Roila, V Ludovini |
Genes & development | 2021 |
Toll-Like Receptor 7 Mediates Inflammation Resolution and Inhibition of Angiogenesis in Non-Small Cell Lung Cancer
F Liotti, M Marotta, D Sorriento, E Pone, F Morra, RM Melillo, N Prevete |
Cancers | 2021 |
Urban air PM modifies differently immune defense responses against bacterial and viral infections in vitro
MA Shahbaz, MV Martikainen, TJ Rönkkö, M Komppula, PI Jalava, M Roponen |
Environmental Research | 2021 |
Integrated Analysis of Nine Prognostic RNA-Binding Proteins in Soft Tissue Sarcoma
LL Lin, ZZ Liu, JZ Tian, X Zhang, Y Zhang, M Yang, HC Zhong, W Fang, RX Wei, C Hu |
Frontiers in Oncology | 2021 |
Toll-like Receptors from the Perspective of Cancer Treatment
N Javaid, S Choi |
Cancers | 2020 |
Toll-like receptors: exploring their potential connection with post-operative infectious complications and cancer recurrence
SD Gowing, JJ Cool-Lartigue, JD Spicer, AJ Seely, LE Ferri |
Clinical & Experimental Metastasis | 2020 |
Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposes
C Patinote, NB Karroum, G Moarbess, N Cirnat, I Kassab, PA Bonnet, C Deleuze-Masquéfa |
European Journal of Medicinal Chemistry | 2020 |
Bidirectional interaction between intestinal microbiome and cancer: opportunities for therapeutic interventions
D Dutta, SH Lim |
Biomarker Research | 2020 |
Toll‐like receptors (TLRs): An old family of immune receptors with a new face in cancer pathogenesis
Y Mokhtari, A PourbagheriSigaroodi, P Zafari, N Bagheri, SH Ghaffari, D Bashash |
Journal of Cellular and Molecular Medicine | 2020 |
Development and validation of a RNA binding protein-associated prognostic model for lung adenocarcinoma
W Li, LN Gao, PP Song, CG You |
Aging | 2020 |
Integrated analysis identifies AQP9 correlates with immune infiltration and acts as a prognosticator in multiple cancers
X Liu, Q Xu, Z Li, B Xiong |
Scientific Reports | 2020 |
Impact of Genetic Variation in TLR4 3′UTR on NSCLC Genetic Susceptibility
H Wu, H Gao, A Li, Y Xie, Z Jia, Z Yang, H Zhang, Z Zhang, X Zhang |
Journal of Oncology | 2020 |
TLRs in pulmonary diseases
S Arora, S Ahmad, R Irshad, Y Goyal, S Rafat, N Siddiqui, K Dev, M Husain, S Ali, A Mohan, MA Syed |
Life Sciences | 2019 |
Toll-Like Receptors and Relevant Emerging Therapeutics with Reference to Delivery Methods
Javaid, Yasmeen, Choi |
Pharmaceutics | 2019 |
Novel Insights reveal Anti-microbial Gene Regulation of Piglet Intestine Immune in response to Clostridium perfringens Infection
XY Huang, WY Sun, ZQ Yan, HR Shi, QL Yang, PF Wang, SG Li, LX Liu, SG Zhao, SB Gun |
Scientific Reports | 2019 |
Pathogen Molecular Pattern Receptor Agonists: Treating Cancer by Mimicking Infection
M Aleynick, J Svensson-Arvelund, CR Flowers, A Marabelle, JD Brody |
Clinical cancer research | 2019 |
TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy
L Huang, H Xu, G Peng |
Cellular and Molecular Immunology | 2018 |
Inflammation and pancreatic cancer: An updated review
K Shadhu, |
Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association | 2018 |
Targeting Toll-Like Receptors for Cancer Therapy
MJ Braunstein, J Kucharczyk, S Adams |
Targeted Oncology | 2018 |
Small Molecules Drive Big Improvements in Immuno-Oncology Therapies
BR Huck, L Kötzner, K Urbahns |
Angewandte Chemie (International ed. in English) | 2018 |
Induction of oligoclonal CD8 T cell responses against pulmonary metastatic cancer by a phospholipid-conjugated TLR7 agonist
T Hosoya, F Sato-Kaneko, A Ahmadi, S Yao, F Lao, K Kitaura, T Matsutani, DA Carson, T Hayashi |
Proceedings of the National Academy of Sciences | 2018 |
Gram-negative bacteria facilitate tumor progression through TLR4/IL-33 pathway in patients with non-small-cell lung cancer
M Sun, Y Bai, S Zhao, X Liu, Y Gao, L Wang, B Liu, D Ma, C Ma |
Oncotarget | 2018 |
Linking common non-coding RNAs of human lung cancer and M. tuberculosis
D Barh, S Tiwari, RN Kumavath, P Ghosh, V Azevedo |
Bioinformation | 2018 |
Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells
M Dajon, K Iribarren, F Petitprez, S Marmier, A Lupo, M Gillard, H Ouakrim, N Victor, DB Vincenzo, PE Joubert, O Kepp, G Kroemer, M Alifano, D Damotte, I Cremer |
OncoImmunology | 2018 |
MUC1-C integrates PD-L1 induction with repression of immune effectors in non-small-cell lung cancer
A Bouillez, H Rajabi, C Jin, M Samur, A Tagde, M Alam, M Hiraki, T Maeda, X Hu, D Adeegbe, S Kharbanda, KK Wong, D Kufe |
Oncogene | 2017 |
Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growth
JC Klein, K Moses, G Zelinskyy, S Sody, J Buer, S Lang, I Helfrich, U Dittmer, CJ Kirschning, S Brandau |
Nature Communications | 2017 |
Anti-tumor Activity of Toll-Like Receptor 7 Agonists
H Chi, C Li, FS Zhao, L Zhang, TB Ng, G Jin, O Sha |
Frontiers in pharmacology | 2017 |
Predictive value of TLR7 polymorphism for cetuximab-based chemotherapy in patients with metastatic colorectal cancer: Predictive value of TLR7 polymorphism for cetuximab
S Okazaki, S Stintzing, Y Sunakawa, S Cao, W Zhang, D Yang, Y Ning, S Matsusaka, MD Berger, Y Miyamoto, M Suenaga, M Schirripa, JD West, R Gopez, T Akihito, W Ichikawa, V Heinemann, RW DePaolo, HJ Lenz |
International Journal of Cancer | 2017 |
Nanoparticles: augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancer
CB Chesson, A Zloza |
Nanomedicine | 2017 |
Toll-like receptor expression in human non-small cell lung carcinoma: potential prognostic indicators of disease
AK Bauer, BL Upham, EA Rondini, MA Tennis, K Velmuragan, D Wiese |
Oncotarget | 2017 |
Roles of toll-like receptors: From inflammation to lung cancer progression (Review)
J Gu, Y Liu, B Xie, P Ye, J Huang, Z Lu |
Biomedical Reports | 2017 |
A Systems Biology Approach Provides Deeper Insights into Differentially Expressed Genes in Taxane-Anthracycline Chemoresistant and Non-Resistant Breast Cancers
Shamim Sarhadi, Somayeh Sadeghi, Fatemeh Nikmanesh, Younes Pilehvar Soltanahmadi, Arman Shahabi, Sedigheh Fekri Aval, Nosratollah Zarghami |
Asian Pacific Journal of Cancer Prevention | 2017 |
Toll-like receptor 5 and 7 expression may impact prognosis of HPV-positive oropharyngeal squamous cell carcinoma patients
Jouhi L, Mohamed H, Mäkitie A, Remes SM, Haglund C, Atula T, Hagström J |
Cancer Immunology, Immunotherapy | 2017 |
Immunomodulation by mesenchymal stem cells in treating human autoimmune disease-associated lung fibrosis
M Liu, X Zeng, J Wang, Z Fu, J Wang, M Liu, D Ren, B Yu, L Zheng, X Hu, W Shi, J Xu |
Stem Cell Research & Therapy | 2016 |
The Role of Toll-Like Receptors in Hematopoietic Malignancies
DA Monlish, ST Bhatt, LG Schuettpelz |
Frontiers in immunology | 2016 |
Interplay between Inflammation and Stemness in Cancer Cells: The Role of Toll-Like Receptor Signaling
DW Yeh, LR Huang, YW Chen, CY Huang, TH Chuang |
Journal of Immunology Research | 2016 |
Decreased expression of TLR7 in gastric cancer tissues and the effects of TLR7 activation on gastric cancer cells
J Jiang, L Dong, B Qin, H Shi, X Guo, Y Wang |
Oncology Letters | 2016 |
Clinical Significance of TLR1 I602S Polymorphism for Patients with Metastatic Colorectal Cancer Treated with FOLFIRI plus Bevacizumab
S Okazaki, F Loupakis, S Stintzing, S Cao, W Zhang, D Yang, Y Ning, Y Sunakawa, S Stremitzer, S Matsusaka, MD Berger, A Parekh, JD West, Y Miyamoto, M Suenaga, M Schirripa, C Cremolini, A Falcone, V Heinemann, RW DePaolo, HJ Lenz |
Molecular cancer therapeutics | 2016 |
Toll Like Receptor 2, 4, and 9 Signaling Promotes Autoregulative Tumor Cell Growth and VEGF/PDGF Expression in Human Pancreatic Cancer
T Grimmig, R Moench, J Kreckel, S Haack, F Rueckert, R Rehder, S Tripathi, C Ribas, A Chandraker, C Germer, M Gasser, A Waaga-Gasser |
International journal of molecular sciences | 2016 |
Reprogramming of TLR7 signaling enhances antitumor NK and cytotoxic T cell responses
C Hotz, M Treinies, I Mottas, LC Rötzer, A Oberson, L Spagnuolo, M Perdicchio, T Spinetti, T Herbst, C Bourquin |
OncoImmunology | 2016 |
Pellino-1 confers chemoresistance in lung cancer cells by upregulating cIAP2 through Lys63-mediated polyubiquitination
YK Jeon, CK Kim, J Koh, DH Chung, GH Ha |
Oncotarget | 2016 |
Dual roles of TLR7 in the lung cancer microenvironment
M Dajon, K Irribarren, I Cremer |
OncoImmunology | 2015 |
Radiation takes its Toll
JA Ratikan, ED Micewicz, MW Xie, D Schaue |
Cancer Letters | 2015 |
Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma—an in vivo and in vitro study
L Jouhi, N Datta, S Renkonen, T Atula, A Mäkitie, C Haglund, A Ahmed, S Syrjänen, R Grénman, E Auvinen, S Lehtonen, J Hagström |
Tumor Biology | 2015 |
Bacille Calmette-Guerin can induce cellular apoptosis of urothelial cancer directly through toll-like receptor 7 activation
DS Yu, CL Wu, SY Ping, C Keng, KH Shen |
The Kaohsiung Journal of Medical Sciences | 2015 |
TLR7 and TLR8 expression increases tumor cell proliferation and promotes chemoresistance in human pancreatic cancer
T Grimmig, N Matthes, K Hoeland, S Tripathi, A Chandraker, M Grimm, R Moench, EM Moll, H Friess, I Tsaur, R Blaheta, C Germer, A Waaga-Gasser, M Gasser |
International journal of oncology | 2015 |
Gonadotropin-mediated chemoresistance: Delineation of molecular pathways and targets
S Sahoo, P Singh, B Kalha, O Singh, R Pal |
BMC Cancer | 2015 |
[Expression of TLR5 in different types of non-small cell lung cancer cell lines and its activation mechanism]
Hui Zhou, Mei Luo, Yige Wen, Andi Ma, Yongzhong Luo, Qing Yi, Jianhua Chen, Ling Xiao |
Zhongguo fei ai za zhi = Chinese journal of lung cancer | 2015 |
TLR8 signaling enhances tumor immunity by preventing tumor-induced T-cell senescence
J Ye, C Ma, EC Hsueh, J Dou, W Mo, S Liu, B Han, Y Huang, Y Zhang, MA Varvares, DF Hoft, G Peng |
EMBO Molecular Medicine | 2014 |
Transient receptor potential ankyrin 1 receptor activation in vitro and in vivo by pro-tussive agents: GRC 17536 as a promising anti-tussive therapeutic
I Mukhopadhyay, A Kulkarni, S Aranake, P Karnik, M Shetty, S Thorat, I Ghosh, D Wale, V Bhosale, N Khairatkar-Joshi |
PloS one | 2014 |
Overexpression of miR-125a in myelodysplastic syndrome CD34+ cells modulates NF-κB activation and enhances erythroid differentiation arrest
I Gañán-Gómez, Y Wei, H Yang, S Pierce, C Bueso-Ramos, G Calin, MD Boyano-Adánez, G García-Manero |
PloS one | 2014 |
High expression of Toll-like receptor 5 correlates with better prognosis in non-small-cell lung cancer: an anti-tumor effect of TLR5 signaling in non-small cell lung cancer
H Zhou, J Chen, J Hu, Y Luo, F Li, L Xiao, M Zhong |
Journal of Cancer Research and Clinical Oncology | 2014 |
The expression of Toll-like receptor 8 and its relationship with VEGF and Bcl-2 in cervical cancer
Y Zhang, H Yang, PA Barnie, P Yang, Z Su, J Chen, Z Jiao, L Lu, S Wang, H Xu |
International journal of medical sciences | 2014 |
Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma
S Deng, S Zhu, Y Qiao, YJ Liu, W Chen, G Zhao, J Chen |
Protein & Cell | 2014 |
Classification of current anticancer immunotherapies
Galluzzi L, Vacchelli E, Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, Bracci L, Caignard A, Castelli C, Cavallo F, Celis E, Cerundolo V, Clayton A, Colombo MP, Coussens L, Dhodapkar MV, Eggermont AM, Fearon DT, Fridman WH, Fučíková J, Gabrilovich DI, Galon J, Garg A, Ghiringhelli F, Giaccone G, Gilboa E, Gnjatic S, Hoos A, Hosmalin A, Jäger D, Kalinski P, Kärre K, Kepp O, Kiessling R, Kirkwood JM, Klein E, Knuth A, Lewis CE, Liblau R, Lotze MT, Lugli E, Mach JP, Mattei F, Mavilio D, Melero I, Melief CJ, Mittendorf EA, Moretta L, Odunsi A, Okada H, Palucka AK, Peter ME, Pienta KJ, Porgador A, Prendergast GC, Rabinovich GA, Restifo NP, Rizvi N, Sautès-Fridman C, Schreiber H, Seliger B, Shiku H, Silva-Santos B, Smyth MJ, Speiser DE, Spisek R, Srivastava PK, Talmadge JE, Tartour E, Van Der Burg SH, Van Den Eynde BJ, Vile R, Wagner H, Weber JS, Whiteside TL, Wolchok JD, Zitvogel L, Zou W, Kroemer G |
Oncotarget | 2014 |
Targeting the tumor microenvironment to enhance antitumor immune responses
Van der Jeught K, Bialkowski L, Daszkiewicz L, Broos K, Goyvaerts C, Renmans D, Van Lint S, Heirman C, Thielemans K, Breckpot K |
Oncotarget | 2014 |
TLR agonists: our best frenemy in cancer immunotherapy
S Kaczanowska, AM Joseph, E Davila |
Journal of leukocyte biology | 2013 |
The Yin and Yang of Toll-like receptors in cancer
JP Pradere, DH Dapito, RF Schwabe |
Oncogene | 2013 |
Autophagy facilitates TLR4- and TLR3-triggered migration and invasion of lung cancer cells through the promotion of TRAF6 ubiquitination
Z Zhan, X Xie, H Cao, X Zhou, XD Zhang, H Fan, Z Liu |
Autophagy | 2013 |
Toll-like receptor 7 stimulates production of specialized pro-resolving lipid mediators and promotes resolution of airway inflammation
O Koltsida, S Karamnov, K Pyrillou, T Vickery, AD Chairakaki, C Tamvakopoulos, P Sideras, CN Serhan, E Andreakos |
EMBO Molecular Medicine | 2013 |
A new role for microRNAs, as ligands of Toll-like receptors
M Fabbri, A Paone, F Calore, R Galli, CM Croce |
RNA biology | 2013 |
Peripheral immune cell gene expression changes in advanced non-small cell lung cancer patients treated with first line combination chemotherapy
YC Chen, CC Hsiao, KD Chen, YC Hung, CY Wu, CH Lie, SF Liu, MT Sung, CJ Chen, TY Wang, JC Chang, P Tang, WF Fang, YH Wang, YH Chung, TY Chao, SY Leung, MC Su, CC Wang, MC Lin |
PloS one | 2013 |
Toll-like receptor-2/6 and Toll-like receptor-9 agonists suppress viral replication but not airway hyperreactivity in guinea pigs
MG Drake, SE Evans, BF Dickey, AD Fryer, DB Jacoby |
American journal of respiratory cell and molecular biology | 2013 |
Toll-Like Receptor 7 Regulates Pancreatic Carcinogenesis
Atsuo Ochi, Christopher Graffeo, Constantinos Zambirinis, Adeel Rehman, Michael Hackman, Nina Fallon, Rocky Barilla, Justin Henning, Mohsin Jamal, Raghavendra Rao, Stephanie Greco, Michael Deutsch, Marco Medina-Zea, Usama Bin Saeed, Melvin Ego-Osuala, Cristina Hajdu, George Miller |
Journal of Clinical Investigation | 2012 |
Therapeutic Applications of Nucleic Acids and Their Analogues in Toll-like Receptor Signaling
V Gosu, S Basith, OP Kwon, S Choi |
Molecules (Basel, Switzerland) | 2012 |
Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer
H Pere, C Tanchot, J Bayry, M Terme, J Taieb, C Badoual, O Adotevi, N Merillon, E Marcheteau, VR Quillien, C Banissi, A Carpentier, F Sandoval, M Nizard, F Quintin-Colonna, G Kroemer, WH Fridman, L Zitvogel, SP Oudard, E Tartour |
OncoImmunology | 2012 |
Development of immune memory to glial brain tumors after tumor regression induced by immunotherapeutic Toll-like receptor 7/8 activation
A Stathopoulos, C Pretto, L Devillers, D Pierre, FM Hofman, C Kruse, M Jadus, TC Chen, VE Schijns |
OncoImmunology | 2012 |
TIR8/SIGIRR is an Interleukin-1 Receptor/Toll Like Receptor Family Member with Regulatory Functions in Inflammation and Immunity
F Riva, E Bonavita, E Barbati, M Muzio, A Mantovani, C Garlanda |
Frontiers in immunology | 2012 |
Trial Watch
L Galluzzi, E Vacchelli, A Eggermont, WH Fridman, J Galon, C Sautès-Fridman, E Tartour, L Zitvogel, G Kroemer |
OncoImmunology | 2012 |
Toll-Like Receptors as Novel Therapeutic Targets for Ovarian Cancer
M Muccioli, L Sprague, H Nandigam, M Pate, F Benencia |
ISRN Oncology | 2012 |
Silencing of Renal DNaseI in Murine Lupus Nephritis Imposes Exposure of Large Chromatin Fragments and Activation of Toll Like Receptors and the Clec4e
D Thiyagarajan, S Fismen, N Seredkina, S Jacobsen, T Elung-Jensen, AL Kamper, CG Fenton, OP Rekvig, ES Mortensen |
PloS one | 2012 |
Immunogenic cell death and DAMPs in cancer therapy
DV Krysko, AD Garg, A Kaczmarek, O Krysko, P Agostinis, P Vandenabeele |
Nature Reviews Cancer | 2012 |
Targeting pattern recognition receptors in cancer immunotherapy
N Goutagny, Y Estornes, U Hasan, S Lebecque, C Caux |
Targeted Oncology | 2012 |
The Therapeutic Potential of Toll-like Receptor 7 Stimulation in Asthma
Drake MG, Kaufman EH, Fryer AD, Jacoby DB |
Inflammation & allergy drug targets | 2012 |
The Toll-like receptor gene family is integrated into human DNA damage and p53 networks
D Menendez, M Shatz, K Azzam, S Garantziotis, MB Fessler, MA Resnick |
PLoS genetics | 2011 |
Lung cancer and Toll-like receptors
A Pinto, S Morello, R Sorrentino |
Cancer Immunology, Immunotherapy | 2011 |
Alterations in the expression of genes related to NF-κB signaling in liver and kidney of CuZnSOD-deficient mice
K Brzóska, B Sochanowicz, A Siomek, R Oliński, M Kruszewski |
Molecular and Cellular Biochemistry | 2011 |
Bacterial immunotherapy of gastrointestinal tumors
M Linnebacher, C Maletzki, U Klier, E Klar |
Langenbeck's Archives of Surgery | 2011 |
Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma
I Sheyhidin, G Nabi, A Hasim, RP Zhang, J Ainiwaer, H Ma, H Wang |
World journal of gastroenterology : WJG | 2011 |
Update in Lung Cancer and Oncological Disorders 2010
B Halmos, CA Powell |
American journal of respiratory and critical care medicine | 2011 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |